CLAIM CARD
Quantitative findings from this pilot trial must be interpreted with caution given its small sample size and exploratory design. The study enrolled 60 participants, a number insufficient for definitive efficacy conclusions but adequate for mechanistic proof-of-concept. Detailed effect sizes, p-values, and confidence intervals for inflammatory biomarker endpoints are presented in the evidence synthesis (Per-Study Endpoint Evidence). The absence of large-scale RCTs or cohort studies with hard inflammatory endpoints means the quantitative signal remains preliminary.
Evidence grade: exploratory
Contradiction status: none
Publication: 4753c82f-24d3-490c-8a23-6cc8d4194c24
Provenance: Derivation Web chain
Citation Support
source_1Ma 2025source_2Schwartz 2021source_3Lehrke 2024source_4Imran 2023source_5Faraidy 2023